Leukocytosis: Difference between revisions
Line 658: | Line 658: | ||
* [[Headache]] | * [[Headache]] | ||
* [[Pharyngitis|Sore throat]] | * [[Pharyngitis|Sore throat]] | ||
*[[Weight loss]] | * [[Weight loss]] | ||
* [[Muscle pain]] | * [[Muscle pain]] | ||
| align="center" style="background:#F5F5F5;" + |↑ | | align="center" style="background:#F5F5F5;" + |↑ | ||
Line 696: | Line 696: | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Strawberry tongue | * Strawberry tongue | ||
* Sore throat | * Sore throat | ||
Line 704: | Line 704: | ||
| align="center" style="background:#F5F5F5;" + |↓ | | align="center" style="background:#F5F5F5;" + |↓ | ||
| align="center" style="background:#F5F5F5;" + |↑ | | align="center" style="background:#F5F5F5;" + |↑ | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Leukocytosis | * Leukocytosis | ||
| align="center" style="background:#F5F5F5;" + |NA | | align="center" style="background:#F5F5F5;" + |NA | ||
Line 711: | Line 711: | ||
| align="center" style="background:#F5F5F5;" + |Nl | | align="center" style="background:#F5F5F5;" + |Nl | ||
| align="center" style="background:#F5F5F5;" + |Diagnostic criteria | | align="center" style="background:#F5F5F5;" + |Diagnostic criteria | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Medium-sized-vessel [[vasculitis]] | * Medium-sized-vessel [[vasculitis]] | ||
* [[Coronary artery aneurysm]] | * [[Coronary artery aneurysm]] | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Inflammatory bowel disease|IBD]] | ! align="center" style="background:#DCDCDC;" |[[Inflammatory bowel disease|IBD]] | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Immune mediated | * Immune mediated | ||
* Mutation | * Mutation | ||
Line 726: | Line 726: | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + |Autoimmune disease, more in young | | align="center" style="background:#F5F5F5;" + |Autoimmune disease, more in young | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Stress | * Stress | ||
* Positive family history | * Positive family history | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Pyoderma gangrenosum | * Pyoderma gangrenosum | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
Line 738: | Line 738: | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Vomiting | * Vomiting | ||
* Diarrhea | * Diarrhea | ||
Line 745: | Line 745: | ||
| align="center" style="background:#F5F5F5;" + |↓ | | align="center" style="background:#F5F5F5;" + |↓ | ||
| align="center" style="background:#F5F5F5;" + |↑ | | align="center" style="background:#F5F5F5;" + |↑ | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Leukocytosis | * Leukocytosis | ||
| align="center" style="background:#F5F5F5;" + |NA | | align="center" style="background:#F5F5F5;" + |NA | ||
Line 752: | Line 752: | ||
| align="center" style="background:#F5F5F5;" + |Nl | | align="center" style="background:#F5F5F5;" + |Nl | ||
| align="center" style="background:#F5F5F5;" + |Colonoscopy and biopsy | | align="center" style="background:#F5F5F5;" + |Colonoscopy and biopsy | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Primary sclerosing cholangitis | * Primary sclerosing cholangitis | ||
* Non-thyroidal illness syndrome | * Non-thyroidal illness syndrome | ||
Line 759: | Line 759: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Sarcoidosis]] | ! align="center" style="background:#DCDCDC;" |[[Sarcoidosis]] | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Immune mediated | * Immune mediated | ||
* Unknown | * Unknown | ||
Line 769: | Line 769: | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + |Autoimmune disease, more in young African American women | | align="center" style="background:#F5F5F5;" + |Autoimmune disease, more in young African American women | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Positive family history | * Positive family history | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Rashes, noduli, erythema nodosum, granuloma annulare, lupus pernio | * Rashes, noduli, erythema nodosum, granuloma annulare, lupus pernio | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
Line 779: | Line 779: | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
Bilateral hilar | Bilateral hilar | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Fatigue | * Fatigue | ||
* Weight loss | * Weight loss | ||
Line 788: | Line 787: | ||
* Shortness of breath | * Shortness of breath | ||
* Cough | * Cough | ||
| align="center" style="background:#F5F5F5;" + |↑ | | align="center" style="background:#F5F5F5;" + |↑ | ||
| align="center" style="background:#F5F5F5;" + |↓ | | align="center" style="background:#F5F5F5;" + |↓ | ||
| align="center" style="background:#F5F5F5;" + |↑ | | align="center" style="background:#F5F5F5;" + |↑ | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Leukocytosis | * Leukocytosis | ||
| align="center" style="background:#F5F5F5;" + |NA | | align="center" style="background:#F5F5F5;" + |NA | ||
Line 799: | Line 797: | ||
| align="center" style="background:#F5F5F5;" + |Nl | | align="center" style="background:#F5F5F5;" + |Nl | ||
| align="center" style="background:#F5F5F5;" + |Diagnosis of exclusion | | align="center" style="background:#F5F5F5;" + |Diagnosis of exclusion | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Interstitial lung disease | * Interstitial lung disease | ||
* Systemic inflammatory disease | * Systemic inflammatory disease | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Hepatitis|Chronic hepatitis]] | ! align="center" style="background:#DCDCDC;" |[[Hepatitis|Chronic hepatitis]] | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Infection | * Infection | ||
* Autoimmune | * Autoimmune | ||
Line 815: | Line 813: | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + |Elderly | | align="center" style="background:#F5F5F5;" + |Elderly | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Alcohol use | * Alcohol use | ||
* Acute infection | * Acute infection | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Jaundice | * Jaundice | ||
* Ascites and peripheral edema | * Ascites and peripheral edema | ||
Line 828: | Line 826: | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Fatigue | * Fatigue | ||
* Weight loss | * Weight loss | ||
* Nausea and vomitting | * Nausea and vomitting | ||
| align="center" style="background:#F5F5F5;" + |↑ | | align="center" style="background:#F5F5F5;" + |↑ | ||
| align="center" style="background:#F5F5F5;" + |↓ | | align="center" style="background:#F5F5F5;" + |↓ | ||
| align="center" style="background:#F5F5F5;" + |↑ | | align="center" style="background:#F5F5F5;" + |↑ | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Leukocytosis | * Leukocytosis | ||
| align="center" style="background:#F5F5F5;" + |NA | | align="center" style="background:#F5F5F5;" + |NA | ||
Line 843: | Line 840: | ||
| align="center" style="background:#F5F5F5;" + |↑ | | align="center" style="background:#F5F5F5;" + |↑ | ||
| align="center" style="background:#F5F5F5;" + |Liver biopsy | | align="center" style="background:#F5F5F5;" + |Liver biopsy | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Hirsutism | * Hirsutism | ||
* Amenorrhea | * Amenorrhea | ||
Line 853: | Line 850: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Sweet's syndrome|Sweet syndrome]] | ! align="center" style="background:#DCDCDC;" |[[Sweet's syndrome|Sweet syndrome]] | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Immune mediated | * Immune mediated | ||
* Unknown | * Unknown | ||
Line 863: | Line 860: | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + |Rare | | align="center" style="background:#F5F5F5;" + |Rare | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Relapse and remission | * Relapse and remission | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Tender, red, well-demarcated papules and plaques on the head, neck, legs, and arms | * Tender, red, well-demarcated papules and plaques on the head, neck, legs, and arms | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
Line 874: | Line 871: | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Conjunctivitis | * Conjunctivitis | ||
* Iridocyclitis | * Iridocyclitis | ||
Line 881: | Line 878: | ||
| align="center" style="background:#F5F5F5;" + |↓ | | align="center" style="background:#F5F5F5;" + |↓ | ||
| align="center" style="background:#F5F5F5;" + |↑ | | align="center" style="background:#F5F5F5;" + |↑ | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Leukocytosis | * Leukocytosis | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Papillary and mid-dermal mixed infiltrate of polymorphonuclear leukocytes with nuclear fragmentation and histiocytic cells | * Papillary and mid-dermal mixed infiltrate of polymorphonuclear leukocytes with nuclear fragmentation and histiocytic cells | ||
| align="center" style="background:#F5F5F5;" + |↑ | | align="center" style="background:#F5F5F5;" + |↑ | ||
Line 889: | Line 886: | ||
| align="center" style="background:#F5F5F5;" + |Nl | | align="center" style="background:#F5F5F5;" + |Nl | ||
| align="center" style="background:#F5F5F5;" + |Diagnostic criteria | | align="center" style="background:#F5F5F5;" + |Diagnostic criteria | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Cutaneous marker of systemic disease | * Cutaneous marker of systemic disease | ||
* Acute myelogenous leukemia | * Acute myelogenous leukemia | ||
Line 896: | Line 893: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Gout|Acute gout]] | ! align="center" style="background:#DCDCDC;" |[[Gout|Acute gout]] | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Elevated levels of uric acid in the blood | * Elevated levels of uric acid in the blood | ||
* Diet | * Diet | ||
* Genetic | * Genetic | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
Line 908: | Line 904: | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + |Older males | | align="center" style="background:#F5F5F5;" + |Older males | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Alcohol use | * Alcohol use | ||
* Acute infection | * Acute infection | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Tophi | * Tophi | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
Line 920: | Line 916: | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Fatigue | * Fatigue | ||
| align="center" style="background:#F5F5F5;" + |↑ | | align="center" style="background:#F5F5F5;" + |↑ | ||
| align="center" style="background:#F5F5F5;" + |↓ | | align="center" style="background:#F5F5F5;" + |↓ | ||
| align="center" style="background:#F5F5F5;" + |↑ | | align="center" style="background:#F5F5F5;" + |↑ | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Leukocytosis | * Leukocytosis | ||
| align="center" style="background:#F5F5F5;" + |NA | | align="center" style="background:#F5F5F5;" + |NA | ||
Line 933: | Line 928: | ||
| align="center" style="background:#F5F5F5;" + |Nl | | align="center" style="background:#F5F5F5;" + |Nl | ||
| align="center" style="background:#F5F5F5;" + |Clinical manifestation | | align="center" style="background:#F5F5F5;" + |Clinical manifestation | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Arthritis | * Arthritis | ||
* Urate nephropathy | * Urate nephropathy | ||
Line 969: | Line 964: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Steroid]] | ! align="center" style="background:#DCDCDC;" |[[Steroid]] | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Release of granulocytes from the bone marrow | * Release of granulocytes from the bone marrow | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
Line 978: | Line 973: | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + |Any | | align="center" style="background:#F5F5F5;" + |Any | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Steroid use | * Steroid use | ||
* Autoimmune disease | * Autoimmune disease | ||
Line 991: | Line 986: | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* [[Abdominal pain]] | * [[Abdominal pain]] | ||
* [[Muscle weakness]] | * [[Muscle weakness]] | ||
Line 999: | Line 994: | ||
| align="center" style="background:#F5F5F5;" + |Nl to ↓ | | align="center" style="background:#F5F5F5;" + |Nl to ↓ | ||
| align="center" style="background:#F5F5F5;" + |↑ | | align="center" style="background:#F5F5F5;" + |↑ | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* [[Myelofibrosis|Megakaryocytic]]<nowiki/>fragments | * [[Myelofibrosis|Megakaryocytic]]<nowiki/>fragments | ||
* Large numbers of microspherocytes | * Large numbers of microspherocytes | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Proliferation of [[Megakaryocyte|megakaryocytes]] | * Proliferation of [[Megakaryocyte|megakaryocytes]] | ||
| align="center" style="background:#F5F5F5;" + |↑ | | align="center" style="background:#F5F5F5;" + |↑ | ||
Line 1,008: | Line 1,003: | ||
| align="center" style="background:#F5F5F5;" + |Nl | | align="center" style="background:#F5F5F5;" + |Nl | ||
| align="center" style="background:#F5F5F5;" + |Clinical manifestation + history of drug consumption | | align="center" style="background:#F5F5F5;" + |Clinical manifestation + history of drug consumption | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* [[Thrombosis|Thromboembolic]]<nowiki/>complications | * [[Thrombosis|Thromboembolic]]<nowiki/>complications | ||
* [[Cushing's syndrome|Cushing syndrome]] | * [[Cushing's syndrome|Cushing syndrome]] | ||
Line 1,014: | Line 1,009: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Filgrastim]] (Myeloid growth factor) | ! align="center" style="background:#DCDCDC;" |[[Filgrastim]] (Myeloid growth factor) | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Release of granulocytes from the bone marrow | * Release of granulocytes from the bone marrow | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
Line 1,023: | Line 1,018: | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + |Any | | align="center" style="background:#F5F5F5;" + |Any | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Malignancy | * Malignancy | ||
* Neutropenia | * Neutropenia | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Hair loss | * Hair loss | ||
* Local skin reactions at the site of injection | * Local skin reactions at the site of injection | ||
Line 1,036: | Line 1,031: | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Cough | * Cough | ||
* Chest pain | * Chest pain | ||
Line 1,048: | Line 1,043: | ||
| align="center" style="background:#F5F5F5;" + |Nl | | align="center" style="background:#F5F5F5;" + |Nl | ||
| align="center" style="background:#F5F5F5;" + |Nl | | align="center" style="background:#F5F5F5;" + |Nl | ||
| align=" | | align="left" style="background:#F5F5F5;" + |Clinical manifestation + history of drug consumption | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* Alveolar hemorrhage | * Alveolar hemorrhage | ||
* Acute respiratory distress syndrome | * Acute respiratory distress syndrome | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Lithium]] | ! align="center" style="background:#DCDCDC;" |[[Lithium]] | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Unknown | * Unknown | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
Line 1,063: | Line 1,058: | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + |Any | | align="center" style="background:#F5F5F5;" + |Any | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Bipolar disorder | * Bipolar disorder | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Weight gain | * Weight gain | ||
* Acne | * Acne | ||
Line 1,076: | Line 1,071: | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* [[Confusion]] | * [[Confusion]] | ||
* [[Constipation]] or [[diarrhea]] | * [[Constipation]] or [[diarrhea]] | ||
Line 1,091: | Line 1,086: | ||
| align="center" style="background:#F5F5F5;" + |Nl | | align="center" style="background:#F5F5F5;" + |Nl | ||
| align="center" style="background:#F5F5F5;" + |Clinical manifestation + history of drug consumption | | align="center" style="background:#F5F5F5;" + |Clinical manifestation + history of drug consumption | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Extrapyramidal side effects | * Extrapyramidal side effects | ||
* Euthyroid goitre | * Euthyroid goitre | ||
Line 1,099: | Line 1,094: | ||
! align="center" style="background:#DCDCDC;" |[[Catecholamine|Catecholamines]] | ! align="center" style="background:#DCDCDC;" |[[Catecholamine|Catecholamines]] | ||
([[epinephrine]]) | ([[epinephrine]]) | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Stimulation of bone marrow myelopoiesis | * Stimulation of bone marrow myelopoiesis | ||
* Egress into the circulation | * Egress into the circulation | ||
Line 1,109: | Line 1,104: | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + |Any | | align="center" style="background:#F5F5F5;" + |Any | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* [[Anaphylaxis]] | * [[Anaphylaxis]] | ||
* Respiratory diseases | * Respiratory diseases | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Acutely ill | * Acutely ill | ||
* Diaphoretic | * Diaphoretic | ||
Line 1,122: | Line 1,117: | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* [[Dizziness]] | * [[Dizziness]] | ||
* [[Tremor]] | * [[Tremor]] | ||
Line 1,130: | Line 1,125: | ||
| align="center" style="background:#F5F5F5;" + |↑ | | align="center" style="background:#F5F5F5;" + |↑ | ||
| align="center" style="background:#F5F5F5;" + |↑ | | align="center" style="background:#F5F5F5;" + |↑ | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* [[Myelofibrosis|Megakaryocytic]]<nowiki/>fragments | * [[Myelofibrosis|Megakaryocytic]]<nowiki/>fragments | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Proliferation of [[Megakaryocyte|megakaryocytes]] | * Proliferation of [[Megakaryocyte|megakaryocytes]] | ||
| align="center" style="background:#F5F5F5;" + |↑ | | align="center" style="background:#F5F5F5;" + |↑ | ||
Line 1,138: | Line 1,133: | ||
| align="center" style="background:#F5F5F5;" + |Nl | | align="center" style="background:#F5F5F5;" + |Nl | ||
| align="center" style="background:#F5F5F5;" + |Clinical manifestation + history of drug consumption | | align="center" style="background:#F5F5F5;" + |Clinical manifestation + history of drug consumption | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* [[Thrombosis|Thromboembolic]]<nowiki/>complications | * [[Thrombosis|Thromboembolic]]<nowiki/>complications | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Tretinoin|ATRA]] | ! align="center" style="background:#DCDCDC;" |[[Tretinoin|ATRA]] | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Differentiating [[Promyelocyte|promyelocytes]] | * Differentiating [[Promyelocyte|promyelocytes]] | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
Line 1,151: | Line 1,146: | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + |Any | | align="center" style="background:#F5F5F5;" + |Any | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Acne | * Acne | ||
* Acute promyelocytic leukemia | * Acute promyelocytic leukemia | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Skin dryness | * Skin dryness | ||
* Hair loss | * Hair loss | ||
Line 1,164: | Line 1,159: | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Shortness of breath | * Shortness of breath | ||
* Headache | * Headache | ||
Line 1,182: | Line 1,177: | ||
| align="center" style="background:#F5F5F5;" + |↑ | | align="center" style="background:#F5F5F5;" + |↑ | ||
| align="center" style="background:#F5F5F5;" + |Clinical manifestation + history of drug consumption | | align="center" style="background:#F5F5F5;" + |Clinical manifestation + history of drug consumption | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Teratogen | * Teratogen | ||
* Thrombosis | * Thrombosis | ||
Line 1,229: | Line 1,224: | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + |Any | | align="center" style="background:#F5F5F5;" + |Any | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Close contact | * Close contact | ||
* Immunodeficiency | * Immunodeficiency | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Acutely ill | * Acutely ill | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
Line 1,241: | Line 1,236: | ||
| align="center" style="background:#F5F5F5;" + |± | | align="center" style="background:#F5F5F5;" + |± | ||
| align="center" style="background:#F5F5F5;" + |± | | align="center" style="background:#F5F5F5;" + |± | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Fatigue | * Fatigue | ||
* Nausea and vomiting | * Nausea and vomiting | ||
| align="center" style="background:#F5F5F5;" + |↑ | | align="center" style="background:#F5F5F5;" + |↑ | ||
| align="center" style="background:#F5F5F5;" + |↓ | | align="center" style="background:#F5F5F5;" + |↓ | ||
| align="center" style="background:#F5F5F5;" + |↑ | | align="center" style="background:#F5F5F5;" + |↑ | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* [[Howell-Jolly body|Howell-Jolly bodies]] | * [[Howell-Jolly body|Howell-Jolly bodies]] | ||
* Nucleated [[Red blood cell|RBCs]] | * Nucleated [[Red blood cell|RBCs]] | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Proliferation of [[Megakaryocyte|megakaryocytes]] | * Proliferation of [[Megakaryocyte|megakaryocytes]] | ||
| align="center" style="background:#F5F5F5;" + |↑ | | align="center" style="background:#F5F5F5;" + |↑ | ||
Line 1,257: | Line 1,251: | ||
| align="center" style="background:#F5F5F5;" + |Nl | | align="center" style="background:#F5F5F5;" + |Nl | ||
| align="center" style="background:#F5F5F5;" + |Clinical manifestation+ culture | | align="center" style="background:#F5F5F5;" + |Clinical manifestation+ culture | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Depends on etiology | * Depends on etiology | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Allergy]] | ! align="center" style="background:#DCDCDC;" |[[Allergy]] | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Unknown | * Unknown | ||
* Activation of chloride transport | * Activation of chloride transport | ||
Line 1,271: | Line 1,265: | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + |Any | | align="center" style="background:#F5F5F5;" + |Any | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* [[Anaphylaxis]] | * [[Anaphylaxis]] | ||
* Respiratory diseases | * Respiratory diseases | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Acutely ill | * Acutely ill | ||
* Diaphoretic | * Diaphoretic | ||
Line 1,284: | Line 1,278: | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* [[Dizziness]] | * [[Dizziness]] | ||
* [[Tremor]] | * [[Tremor]] | ||
Line 1,292: | Line 1,286: | ||
| align="center" style="background:#F5F5F5;" + |↑ | | align="center" style="background:#F5F5F5;" + |↑ | ||
| align="center" style="background:#F5F5F5;" + |↑ | | align="center" style="background:#F5F5F5;" + |↑ | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* [[Myelofibrosis|Megakaryocytic]]<nowiki/>fragments | * [[Myelofibrosis|Megakaryocytic]]<nowiki/>fragments | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Proliferation of [[Megakaryocyte|megakaryocytes]] | * Proliferation of [[Megakaryocyte|megakaryocytes]] | ||
| align="center" style="background:#F5F5F5;" + |↑ | | align="center" style="background:#F5F5F5;" + |↑ | ||
Line 1,303: | Line 1,297: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |Post [[splenectomy]] | ! align="center" style="background:#DCDCDC;" |Post [[splenectomy]] | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Unknown | * Unknown | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
Line 1,312: | Line 1,306: | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + |Any | | align="center" style="background:#F5F5F5;" + |Any | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Prior surgical removal of the spleen | * Prior surgical removal of the spleen | ||
* [[Sickle-cell disease|Sickle cell disease]] | * [[Sickle-cell disease|Sickle cell disease]] | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Normal | * Normal | ||
| align="center" style="background:#F5F5F5;" + |± | | align="center" style="background:#F5F5F5;" + |± | ||
Line 1,328: | Line 1,322: | ||
| align="center" style="background:#F5F5F5;" + |↓ | | align="center" style="background:#F5F5F5;" + |↓ | ||
| align="center" style="background:#F5F5F5;" + |↑ | | align="center" style="background:#F5F5F5;" + |↑ | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* [[Howell-Jolly body|Howell-Jolly bodies]] | * [[Howell-Jolly body|Howell-Jolly bodies]] | ||
* Nucleated [[Red blood cell|RBCs]] | * Nucleated [[Red blood cell|RBCs]] | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Proliferation of [[Megakaryocyte|megakaryocytes]] | * Proliferation of [[Megakaryocyte|megakaryocytes]] | ||
| align="center" style="background:#F5F5F5;" + |↑ | | align="center" style="background:#F5F5F5;" + |↑ | ||
Line 1,337: | Line 1,331: | ||
| align="center" style="background:#F5F5F5;" + |Nl | | align="center" style="background:#F5F5F5;" + |Nl | ||
| align="center" style="background:#F5F5F5;" + |Clinical manifestation | | align="center" style="background:#F5F5F5;" + |Clinical manifestation | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Incidental laboratory finding | * Incidental laboratory finding | ||
* [[Thrombosis]] | * [[Thrombosis]] | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Smoking|Cigarette smoking]] | ! align="center" style="background:#DCDCDC;" |[[Smoking|Cigarette smoking]] | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Reduced plasma volume | * Reduced plasma volume | ||
* Accelerated [[erythropoiesis]] | * Accelerated [[erythropoiesis]] | ||
Line 1,352: | Line 1,346: | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + |Any | | align="center" style="background:#F5F5F5;" + |Any | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* [[Smoking|Cigarette smoking]] | * [[Smoking|Cigarette smoking]] | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* [[Cyanosis]] | * [[Cyanosis]] | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
Line 1,363: | Line 1,357: | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Cough | * Cough | ||
* [[Dyspnea]] | * [[Dyspnea]] | ||
Line 1,378: | Line 1,372: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Stress (medicine)|Stress]]/[[Physical exercise|exercise]] | ! align="center" style="background:#DCDCDC;" |[[Stress (medicine)|Stress]]/[[Physical exercise|exercise]] | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Reduced plasma volume | * Reduced plasma volume | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
Line 1,387: | Line 1,381: | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + |Athlete | | align="center" style="background:#F5F5F5;" + |Athlete | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Exercise | * Exercise | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Normal | * Normal | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
Line 1,402: | Line 1,396: | ||
| align="center" style="background:#F5F5F5;" + |↑ | | align="center" style="background:#F5F5F5;" + |↑ | ||
| align="center" style="background:#F5F5F5;" + |↑ | | align="center" style="background:#F5F5F5;" + |↑ | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* [[Howell-Jolly body|Howell-Jolly bodies]] | * [[Howell-Jolly body|Howell-Jolly bodies]] | ||
* Nucleated [[Red blood cell|RBCs]] | * Nucleated [[Red blood cell|RBCs]] | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Proliferation of [[Megakaryocyte|megakaryocytes]] | * Proliferation of [[Megakaryocyte|megakaryocytes]] | ||
| align="center" style="background:#F5F5F5;" + |↑ | | align="center" style="background:#F5F5F5;" + |↑ | ||
Line 1,423: | Line 1,417: | ||
| align="center" style="background:#F5F5F5;" + |Infancy | | align="center" style="background:#F5F5F5;" + |Infancy | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Normal | * Normal | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
Line 1,454: | Line 1,448: | ||
| align="center" style="background:#F5F5F5;" + |Pregnancy | | align="center" style="background:#F5F5F5;" + |Pregnancy | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Normal | * Normal | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
Line 1,485: | Line 1,479: | ||
| align="center" style="background:#F5F5F5;" + |Any | | align="center" style="background:#F5F5F5;" + |Any | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Normal | * Normal | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
Line 1,498: | Line 1,492: | ||
| align="center" style="background:#F5F5F5;" + |Nl | | align="center" style="background:#F5F5F5;" + |Nl | ||
| align="center" style="background:#F5F5F5;" + |↑ | | align="center" style="background:#F5F5F5;" + |↑ | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Cytoplasmic fragments | * Cytoplasmic fragments | ||
| align="center" style="background:#F5F5F5;" + |Nl | | align="center" style="background:#F5F5F5;" + |Nl | ||
Line 1,516: | Line 1,510: | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + |Any | | align="center" style="background:#F5F5F5;" + |Any | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* [[Cancer|Malignancy]] | * [[Cancer|Malignancy]] | ||
* [[Autoimmune disease]] | * [[Autoimmune disease]] | ||
* [[Infection]] | * [[Infection]] | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Atypical cutaneous ulcers | * Atypical cutaneous ulcers | ||
* Palpable [[purpura]] | * Palpable [[purpura]] | ||
Line 1,530: | Line 1,524: | ||
| align="center" style="background:#F5F5F5;" + |− | | align="center" style="background:#F5F5F5;" + |− | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* [[Headache]] | * [[Headache]] | ||
* [[Confusion]] | * [[Confusion]] | ||
Line 1,538: | Line 1,532: | ||
| align="center" style="background:#F5F5F5;" + |Nl to ↓ | | align="center" style="background:#F5F5F5;" + |Nl to ↓ | ||
| align="center" style="background:#F5F5F5;" + |↑ | | align="center" style="background:#F5F5F5;" + |↑ | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* Cytoplasmic fragments | * Cytoplasmic fragments | ||
| align="center" style="background:#F5F5F5;" + |Nl | | align="center" style="background:#F5F5F5;" + |Nl | ||
Line 1,545: | Line 1,539: | ||
| align="center" style="background:#F5F5F5;" + |Nl | | align="center" style="background:#F5F5F5;" + |Nl | ||
| align="center" style="background:#F5F5F5;" + |[[Skin biopsy]] | | align="center" style="background:#F5F5F5;" + |[[Skin biopsy]] | ||
| align=" | | align="left" style="background:#F5F5F5;" + | | ||
* [[Vasculitis]] | * [[Vasculitis]] | ||
* [[Neuropathy]] | * [[Neuropathy]] |
Revision as of 21:07, 29 September 2018
WikiDoc Resources for Leukocytosis |
Articles |
---|
Most recent articles on Leukocytosis Most cited articles on Leukocytosis |
Media |
Powerpoint slides on Leukocytosis |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Leukocytosis at Clinical Trials.gov Clinical Trials on Leukocytosis at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Leukocytosis
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Leukocytosis Discussion groups on Leukocytosis Patient Handouts on Leukocytosis Directions to Hospitals Treating Leukocytosis Risk calculators and risk factors for Leukocytosis
|
Healthcare Provider Resources |
Causes & Risk Factors for Leukocytosis |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2] Lakshmi Gopalakrishnan, M.B.B.S. [3]
Synonyms and keywords: Elevated white blood cell count; Right-shift leukocytosis; Left-leukocytosis
Overview
Leukocytosis is an elevation of the white blood cell count above the normal range (greater than 11,000 per mm3). Leukocytosis is frequently a sign of an inflammatory response, most commonly the result of infection, but may also occur following certain parasitic infections, bone tumors, strenuous exercise, emotional stress, pregnancy, anesthesia, and epinephrine administration. Leukocytosis may be classified into 5 subtypes: neutrophilia (most common), lymphocytosis, monocytosis, eosinophilia, and basophilia. Other classification, include: Left shift or right shift leucocytosis. The pathogenesis of leukocytosis is characterized by the increase of leukocytes (primarily neutrophils), followed by the proliferation and release of granulocyte and monocyte precursors in the bone marrow which is stimulated by several products of inflammation including C3a and G-CSF.[1]
Historical Perspective
- Leukocytosis was first discovered by Paul Kautchakoff, in 1846.[1]
Classification
- Leukocytosis may be classified into 5 subtypes:[2]
- Neutrophilia (most common)
- Lymphocytosis
- Monocytosis
- Eosinophilia
- Basophilia.
- Leukocytosis may also be classified into 2 groups:[2]
- Left shift (most common)
- Immature leukocytes increase
- Proliferation and release of granulocyte and monocyte precursors in the bone marrow
- Usually stimulated by several products of inflammation including C3a and G-CSF
- Right shift
- Reduced count or lack of "young neutrophils"
- Associated with the presence of "giant neutrophils
- Other variant of leukocytosis is the leukemoid reaction.
- The image below demonstrates a graphic figure that illustrates hematopoietic growth factors in leukocytosis.[3]
-
Hematopoietic growth factors in leukocytosis
Courtesy of Wikipedia
Pathophysiology
- The pathogenesis of leukocytosis is characterized by:[2]
- An increased release of leukocytes from bone marrow storage pools
- Decreased margination of leukocytes onto vessel walls
- Decreased extravasation of leukocytes from the vessels into tissues
- Increase in number of precursor cells in the marrow
Causes
- To see a comprehensive list of all causes of leukocytosis, please click here
Causes of leukocytosis | ||||
---|---|---|---|---|
Neutrophilic leukocytosis (neutrophilia) |
||||
Eosinophilic leukocytosis (eosinophilia) |
| |||
Basophilic leukocytosis Basophilia |
||||
Monocytosis | ||||
Lymphocytosis |
|
Epidemiology and Demographics
- Leukocytosis is very common.[2]
Age
- Patients of all age groups may develop leukocytosis.
- Normal white blood count differential changes with age.
- Leukocytosis in neonates is more common, compared to children and adults.[2]
Gender
- Leukocytosis affects men and women equally.
Race
- There is no racial predilection for leukocytosis.
Risk Factors
- Common risk factors in the development of leukocytosis, include:[2]
- Physiologic processes (eg, stress, exercise, pregnancy)
- Drugs (e.g.corticosteroids, lithium, beta agonists)
- Trauma
- Stress
Natural History, Complications and Prognosis
- The majority of patients with leukocytosis are initially symptomatic.[3]
- Early clinical features, include:[3]
- Fever
- Hyperhidrosis
- Fatigue
- Common complications of leukocytosis, include:[3]
- Tumor lysis syndrome
- Disseminated intravascular coagulopathy
- Acute respiratory failure
- Pulmonary hemorrhage
- CNS infarction
- Splenic infarction
- Myocardial ischemia
- Renal failure
- Prognosis is generally depends on the underlying etiologies.[3]
Diagnosis
Symptoms
- Leukocytosis is usually symptomatic.
- Symptoms of leukocytosis are often unspecific, such as:[3]
- Weight loss
- Fevers of unknown origin
- Hyperhidrosis
- Chronic pain
- Fatigue
- Dyspnea
- Malaise
- Obtain history of the following:
- Clinical features
- Duration (e.g. days, weeks, months)
- Remainder of complete blood count
Laboratory Findings
- Laboratory findings consistent with the diagnosis of leukocytosis, include:[3]
- White blood cell count above the normal range
- Greater than 11,000 per mm3
Differentiating Leukocytosis from Other Diseases
Category | Condition | Etiology | Mechanism | Congenital | Acquried | Clinical manifestations | Para−clinical findings | Gold standard | Associated findings | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Demography | History | Symptoms | Signs | ||||||||||||||||||||||||||
Lab Findings | |||||||||||||||||||||||||||||
Physiologic | Increased bone marrow production | Demargination of peripheral blood neutrophils | Appearance | Fever | Abdominal pain | BP | Asplenia | Hepatosplenomegaly | Lymphadenopathy | Joint involvement | Other | CBC | PBS | Bone marrow exam | ESR/CRP | BUN/Cr | LFT | ||||||||||||
Autonomous | Reactive | WBC | HB | Plt | |||||||||||||||||||||||||
Hematologic | Hereditary neutrophilia[4] | − | + | − | − | + | − | Rare autosomal dominant genetic disorder |
|
Normal | − | − | Nl | − | + | − | − | − | ↑ | Nl | Nl |
|
Nl | Nl | Nl | Nl | Molecular testing |
| |
Myeloproliferative neoplasms[5] |
|
− | + | − | − | + | + | Elderly | Exposure to | ± | + | Nl | − | + | − | − | ↑/↓ | ↓ | ↑/↓ |
|
|
↑ | Nl | Nl | Bone marrow examination + clinical manifestation |
| |||
Polycythemia vera[6] |
|
− | + | − | − | + | − | Mean age >60 years old |
|
− | − | ↑ | − | + | + | − |
|
Nl to ↑ | ↑ | ↑ |
|
|
Nl | Nl | Nl | Bone marrow examination + clinical manifestation | |||
Microangiopathic hemolytic anemia (MAHA)[7] | − | + | − | − | + | + | Any |
|
+ | + | ↓ | − | + | − | − | ↑ | ↓ | ↑ |
|
NA | ↑ | ↑ | ↑ | Bone marrow examination + clinical manifestation |
| ||||
Leukoerythroblastosis[8] |
|
− | + | − | − | − | + | Any | − | + | Nl | − | + | − | − |
|
↑ | ↓ | ↓ |
|
|
↑ | Nl | ↑ | Bone marrow biopsy |
| |||
Immunology/
Rheumatology |
Condition | Etiology | Physiologic | Autonomous increased bone marrow production | Reactive increased bone marrow production | Demargination of peripheral blood neutrophils | Congenital | Acquried | Demography | History | Appearance | Fever | Abdominal pain | BP | Asplenia | Hepatosplenomegaly | Lymphadenopathy | Joint involvement | Other signs | WBC | HB | Plt | PBS | Bone marrow exam | ESR/CRP | BUN/Cr | LFT | Gold standard | Associated findings |
Leukocyte adhesion deficiency[9] |
|
− | + | − | − | + | − | Rare autosomal recessive, LAD II more in Middle East and Brazil |
|
|
+ | − | Nl | − | − | − | − |
|
↑ | ↓ | ↓/↑ |
|
|
Nl | Nl | Nl | Flow cytometry |
| |
Cryopyrin-associated periodic syndromes[10] |
|
− | + | − | − | + | − | Autosomal dominant autoinflammatory syndrome |
|
|
+ | − | Nl | − | − | − | + | ↑ | ↓ | ↓/↑ |
|
|
↑ | Nl | ↑ | Genetic tests | |||
Rheumatoid arthritis[11][12] |
|
− | + | − | − | − | + | Any, more in young women, between 30-60 years old |
|
|
+ | − | Nl | − | − | − | + |
|
↑ | ↓ | ↑ |
|
NA | ↑ | Nl | Nl | Clinical manifestation + positive anti-CCP antibodies |
| |
Juvenile onset rheumatoid arthritis[13] |
|
− | + | − | − | − | + | Children under the age of 16 |
|
|
+ | − | Nl | − | − | + | + |
|
↑ | ↓ | ↑ |
|
NA | ↑ | Nl | Nl | Clinical manifestation + laboratory findings |
| |
Adult Still's disease |
|
− | + | − | − | − | + | Rare autoimmune disease | NA | + | − | Nl | − | − | + | + | ↑ | ↓ | ↑ |
|
NA | ↑ | Nl | Nl | Diagnosis of exclusion |
| |||
Kawasaki disease |
|
− | + | − | − | − | + | Autoimmune disease, more in Asian ethnicity boys | NA |
|
+ | + | Nl | − | − | + | + |
|
↑ | ↓ | ↑ |
|
NA | ↑ | Nl | Nl | Diagnostic criteria |
| |
IBD |
|
− | + | − | − | − | + | Autoimmune disease, more in young |
|
|
+ | + | Nl | − | + | + | + |
|
↑ | ↓ | ↑ |
|
NA | ↑ | Nl | Nl | Colonoscopy and biopsy |
| |
Sarcoidosis |
|
− | + | − | − | − | + | Autoimmune disease, more in young African American women |
|
|
+ | + | Nl | − | + | +
Bilateral hilar |
+ |
|
↑ | ↓ | ↑ |
|
NA | ↑ | Nl | Nl | Diagnosis of exclusion |
| |
Chronic hepatitis |
|
− | + | − | − | − | + | Elderly |
|
|
+ | + | ↓ | − | + | + | + |
|
↑ | ↓ | ↑ |
|
NA | ↑ | ↑ | ↑ | Liver biopsy |
| |
Sweet syndrome |
|
− | + | − | − | − | + | Rare |
|
|
+ | + | Nl | − | − | + | + |
|
↑ | ↓ | ↑ |
|
|
↑ | Nl | Nl | Diagnostic criteria |
| |
Acute gout |
|
− | + | − | − | − | + | Older males |
|
|
+ | − | − | − | − | + |
|
↑ | ↓ | ↑ |
|
NA | ↑ | ↑ | Nl | Clinical manifestation |
| ||
Medication | Condition | Etiology | Physiologic | Autonomous increased bone marrow production | Reactive increased bone marrow production | Demargination of peripheral blood neutrophils | Congenital | Acquried | Demography | History | Appearance | Fever | Abdominal pain | BP | Asplenia | Hepatosplenomegaly | Lymphadenopathy | Joint involvement | Other signs | WBC | HB | Plt | PBS | Bone marrow exam | ESR/CRP | BUN/Cr | LFT | Gold standard | Associated findings |
Steroid |
|
− | − | + | + | − | + | Any |
|
|
− | + | Nl to ↓ | − | − | − | − | ↑ | Nl to ↓ | ↑ |
|
|
↑ | ↑ | Nl | Clinical manifestation + history of drug consumption |
| ||
Filgrastim (Myeloid growth factor) |
|
− | − | + | + | − | + | Any |
|
|
+ | − | Nl to ↓ | − | − | − | + |
|
↑ | Nl to ↓ | ↑ | NA | NA | ↑ | Nl | Nl | Clinical manifestation + history of drug consumption |
| |
Lithium |
|
− | − | + | + | − | + | Any |
|
|
− | − | Nl | − | − | − | − |
|
↑ | Nl to ↓ | ↑ | NA | NA | Nl | ↑ | Nl | Clinical manifestation + history of drug consumption |
| |
Catecholamines |
|
− | − | + | + | − | + | Any |
|
|
− | − | Nl to ↓ | − | − | − | − | ↑ | ↑ | ↑ |
|
|
↑ | Nl | Nl | Clinical manifestation + history of drug consumption |
| ||
ATRA |
|
− | − | + | + | − | + | Any |
|
|
− | − | Nl | − | − | − | − |
|
↑ | Nl | Nl | NA | NA | ↑ | Nl | ↑ | Clinical manifestation + history of drug consumption |
| |
Other | Condition | Etiology | Physiologic | Autonomous increased bone marrow production | Reactive increased bone marrow production | Demargination of peripheral blood neutrophils | Congenital | Acquried | Demography | History | Appearance | Fever | Abdominal pain | BP | Asplenia | Hepatosplenomegaly | Lymphadenopathy | Joint involvement | Other signs | WBC | HB | Plt | PBS | Bone marrow exam | ESR/CRP | BUN/Cr | LFT | Gold standard | Associated findings |
Infections | Infection | − | + | + | + | − | + | Any |
|
|
+ | + | Nl to ↓ | − | ± | ± | ± |
|
↑ | ↓ | ↑ |
|
|
↑ | Nl | Nl | Clinical manifestation+ culture |
| |
Allergy |
|
− | + | + | + | − | + | Any |
|
|
− | − | Nl to ↓ | − | − | − | − | ↑ | ↑ | ↑ |
|
|
↑ | Nl | Nl | Clinical manifestation | − | ||
Post splenectomy |
|
− | − | + | + | − | + | Any |
|
|
± | − | Nl | + | − | − | − | − | ↑ | ↓ | ↑ |
|
|
↑ | Nl | Nl | Clinical manifestation |
| |
Cigarette smoking |
|
− | − | + | + | − | + | Any | − | − | Nl | − | − | − | − |
|
↑ | ↑ | ↑ | NA | NA | Nl | Nl | Nl | Clinical manifestation | − | |||
Stress/exercise |
|
+ | − | + | − | − | + | Athlete |
|
|
− | − | Nl | − | − | − | − | − | ↑ | ↑ | ↑ |
|
|
↑ | Nl | Nl | Clinical manifestation | − | |
Infancy | Physiologic | + | − | − | − | − | + | Infancy | − |
|
− | − | Nl | − | − | − | − | − | ↑ | ↑ | ↑ | NA | NA | Nl | Nl | Nl | Clinical manifestation | − | |
Pregnancy | Physiologic | + | − | − | − | − | + | Pregnancy | − |
|
− | − | Nl | − | − | − | − | − | ↑ | ↓ | ↑ | NA | NA | Nl | Nl | Nl | Clinical manifestation | − | |
Platelet clumping | Spurious | − | − | − | − | − | + | Any | − |
|
− | − | Nl | − | − | − | − | − | ↑ | Nl | ↑ |
|
Nl | Nl | Nl | Nl | Clinical manifestation | − | |
Mixed cryoglobulinemia | Spurious | − | − | − | − | − | + | Any |
|
− | − | Nl | − | − | − | + | ↑ | Nl to ↓ | ↑ |
|
Nl | Nl | Nl | Nl | Skin biopsy | ||||
Category | Condition | Etiology | Physiologic | Autonomous increased bone marrow production | Reactive increased bone marrow production | Demargination of peripheral blood neutrophils | Congenital | Acquried | Demography | History | Appearance | Fever | Abdominal pain | BP | Asplenia | Hepatosplenomegaly | Lymphadenopathy | Joint involvement | Other signs | WBC | HB | Plt | PBS | Bone marrow exam | ESR/CRP | BUN/Cr | LFT | Gold standard | Associated findings |
Treatment
Medical Therapy
- The treatment for leukocytosis will depend on the underlying condition.[3]
References
- ↑ 1.0 1.1 Chabot-Richards DS, George TI (2014). "Leukocytosis". Int J Lab Hematol. 36 (3): 279–88. doi:10.1111/ijlh.12212. PMID 24750674.
- ↑ 2.0 2.1 2.2 2.3 2.4 2.5 Abramson N, Melton B (2000). "Leukocytosis: basics of clinical assessment". Am Fam Physician. 62 (9): 2053–60. PMID 11087187.
- ↑ 3.0 3.1 3.2 3.3 3.4 3.5 3.6 3.7 Leukocytosis. Wikipedia. https://en.wikipedia.org/wiki/Leukocytosis Accessed on May 23, 2016
- ↑ Herring, William Benjamin; Smith, Laurin Gresham; Walker, Richard Isley; Herion, John Carroll (1974). "Hereditary neutrophilia". The American Journal of Medicine. 56 (5): 729–734. doi:10.1016/0002-9343(74)90642-1. ISSN 0002-9343.
- ↑ Tefferi A (February 2010). "Leukocytosis as a risk factor for thrombosis in myeloproliferative neoplasms-biologically plausible but clinically uncertain". Am. J. Hematol. 85 (2): 93–4. doi:10.1002/ajh.21614. PMID 20052751.
- ↑ Boiocchi L, Gianelli U, Iurlo A, Fend F, Bonzheim I, Cattaneo D, Knowles DM, Orazi A (November 2015). "Neutrophilic leukocytosis in advanced stage polycythemia vera: hematopathologic features and prognostic implications". Mod. Pathol. 28 (11): 1448–57. doi:10.1038/modpathol.2015.100. PMID 26336886.
- ↑ Morton JM, George JN (June 2016). "Microangiopathic Hemolytic Anemia and Thrombocytopenia in Patients With Cancer". J Oncol Pract. 12 (6): 523–30. doi:10.1200/JOP.2016.012096. PMID 27288467.
- ↑ Canbolat Ayhan A, Timur C, Ayhan Y, Kes G (June 2014). "Leukoerythroblastosis Mimicking Leukemia: A case report". Iran J Pediatr. 24 (3): 332–3. PMC 4276592. PMID 25562031.
- ↑ Levy-Mendelovich S, Rechavi E, Abuzaitoun O, Vernitsky H, Simon AJ, Lev A, Somech R (April 2016). "Highlighting the problematic reliance on CD18 for diagnosing leukocyte adhesion deficiency type 1". Immunol. Res. 64 (2): 476–82. doi:10.1007/s12026-015-8706-5. PMID 26434744.
- ↑ Labrousse M, Kevorkian-Verguet C, Boursier G, Rowczenio D, Maurier F, Lazaro E, Aggarwal M, Lemelle I, Mura T, Belot A, Touitou I, Sarrabay G (September 2018). "Mosaicism in autoinflammatory diseases: Cryopyrin-associated periodic syndromes (CAPS) and beyond. A systematic review". Crit Rev Clin Lab Sci. 55 (6): 432–442. doi:10.1080/10408363.2018.1488805. PMID 30035647.
- ↑ Scott DL, Wolfe F, Huizinga TW (September 2010). "Rheumatoid arthritis". Lancet. 376 (9746): 1094–108. doi:10.1016/S0140-6736(10)60826-4. PMID 20870100.
- ↑ Glant TT, Mikecz K, Rauch TA (February 2014). "Epigenetics in the pathogenesis of rheumatoid arthritis". BMC Med. 12: 35. doi:10.1186/1741-7015-12-35. PMC 3936819. PMID 24568138.
- ↑ Naz S, Mushtaq A, Rehman S, Bari A, Maqsud A, Khan MZ, Ahmad TM (June 2013). "Juvenile rheumatoid arthritis". J Coll Physicians Surg Pak. 23 (6): 409–12. doi:06.2013/JCPSP.409412 Check
|doi=
value (help). PMID 23763801.